Share on Facebook
Share on Twitter
Share on LinkedIn
Share by Email
Print
Tri-luma Generic Name & Formulations
Legal Class
Rx
General Description
Hydroquinone 4%, fluocinolone acetonide 0.01%, tretinoin 0.05%; crm; contains sulfites, parabens.
Pharmacological Class
Skin depigmenting agent + topical steroid + retinoid.
How Supplied
Crm—30g
Manufacturer
Tri-luma Indications
Indications
Short-term intermittent treatment of moderate to severe melasma of the face, with measures for sun avoidance including sunscreen use (SPF 30).
Tri-luma Dosage and Administration
Adult
Clean (use a mild, soap-free cleanser) and dry skin. Apply a thin film to affected area(s) and to ½ inch of surrounding normal skin once daily, at least 30 minutes before bedtime.
Children
Not recommended.
Tri-luma Contraindications
Not Applicable
Tri-luma Boxed Warnings
Not Applicable
Tri-luma Warnings/Precautions
Warnings/Precautions
Do not occlude or use on eczema or sunburned skin. Avoid eyes, ears, mouth, angle of nose, mucous membranes, sun, UV light. Skin types V and VI (possible undesirable excessive bleaching). Discontinue if ochronosis, chemical irritation, hypersensitivity, or HPA axis suppression occurs. Increased irritation in extreme weather. Elderly. Pregnancy (Cat.C), nursing mothers: consider delaying use until after pregnancy/nursing.
Tri-luma Pharmacokinetics
See Literature
Tri-luma Interactions
Interactions
Avoid photosensitizers, topical irritants, and drying agents.
Tri-luma Adverse Reactions
Adverse Reactions
Local irritation (erythema, peeling, burning, dryness, pruritus), acne, paresthesia, telangiectasia, hyperesthesia, folliculitis, dermatitis, secondary infection, hypertrichosis, skin atrophy, striae, miliaria, HPA axis suppression.
Tri-luma Clinical Trials
See Literature
Tri-luma Note
Not Applicable
Tri-luma Patient Counseling
See Literature
Images
